Rocamed
Entry
2024
Hold
2yr
Status
Active
Who owns Rocamed?
Rocamed is currently owned by 21 Invest through 21 Invest France Fund VI (2022 vintage), since 2024. Across its history, Rocamed has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
21 Invest21 Invest France Fund VI · 2022 · Buyout
3 ownership periods · full history below
Key facts
HQFrance
SectorMedTech
Ownership history
2 ownership periods · co-invest detected · 1 lender on file
Active
Co-invest · 2 holders · 1 lender · 2018 · present
Stags ParticipationsActive
2018 · present(8yr) · Stags Participations · 2011 · Growth
Zencap AMLender
2024 · present(2yr) · Zencap Direct Lending IV · 2023 · Private Debt
21 InvestActive
2024 · present(2yr) · 21 Invest France Fund VI · 2022 · Buyout
More from 21 Invest France Fund VI
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Track Rocamed
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Rocamed?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Rocamed.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue